Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001440096 | SCV001643000 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-02-11 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800995 | SCV002046752 | uncertain significance | not provided | 2021-03-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002414049 | SCV002674827 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230674 | SCV003928229 | likely benign | not specified | 2023-04-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004007012 | SCV004845557 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-11-02 | criteria provided, single submitter | clinical testing |